Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma.
|
J Natl Cancer Inst
|
2002
|
4.43
|
2
|
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.
|
Oncogene
|
2003
|
3.34
|
3
|
Frequency of TERT promoter mutations in human cancers.
|
Nat Commun
|
2013
|
3.13
|
4
|
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma.
|
Gastroenterology
|
2003
|
2.39
|
5
|
BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
|
J Pathol
|
2004
|
2.21
|
6
|
The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors.
|
Mod Pathol
|
2011
|
2.08
|
7
|
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
|
J Clin Endocrinol Metab
|
2014
|
1.71
|
8
|
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.
|
Virchows Arch
|
2005
|
1.62
|
9
|
Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
|
Am J Pathol
|
2002
|
1.61
|
10
|
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
|
J Pathol
|
2004
|
1.59
|
11
|
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas.
|
J Clin Endocrinol Metab
|
2004
|
1.52
|
12
|
How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer.
|
J Thyroid Res
|
2011
|
1.46
|
13
|
Carcinoma of the thyroid with ewing family tumor elements and favorable prognosis: report of a second case.
|
Int J Surg Pathol
|
2013
|
1.46
|
14
|
Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines.
|
Thyroid
|
2007
|
1.41
|
15
|
Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma.
|
Virchows Arch
|
2001
|
1.30
|
16
|
STAT3 negatively regulates thyroid tumorigenesis.
|
Proc Natl Acad Sci U S A
|
2012
|
1.23
|
17
|
Oncocytic lesions of the thyroid, kidney, salivary glands, adrenal cortex, and parathyroid glands.
|
Int J Surg Pathol
|
2014
|
1.10
|
18
|
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
|
Virchows Arch
|
2014
|
1.09
|
19
|
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma.
|
J Clin Endocrinol Metab
|
2012
|
1.08
|
20
|
A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma.
|
Hum Pathol
|
2005
|
1.04
|
21
|
Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests.
|
Mod Pathol
|
2004
|
1.01
|
22
|
High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
|
J Clin Endocrinol Metab
|
2007
|
1.01
|
23
|
p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin.
|
Mod Pathol
|
2003
|
0.99
|
24
|
Mucins as key molecules for the classification of intestinal metaplasia of the stomach.
|
Virchows Arch
|
2001
|
0.98
|
25
|
BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas.
|
Virchows Arch
|
2004
|
0.95
|
26
|
Prognostic biomarkers in thyroid cancer.
|
Virchows Arch
|
2014
|
0.95
|
27
|
Patterns of beta-catenin expression in gastric carcinoma: clinicopathological relevance and mutation analysis.
|
Int J Surg Pathol
|
2003
|
0.93
|
28
|
The biology and the genetics of Hurthle cell tumors of the thyroid.
|
Endocr Relat Cancer
|
2012
|
0.92
|
29
|
Molecular genetics of papillary thyroid carcinoma: great expectations.
|
Arq Bras Endocrinol Metabol
|
2007
|
0.92
|
30
|
Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior.
|
Am J Clin Pathol
|
2009
|
0.91
|
31
|
B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas.
|
Hum Pathol
|
2006
|
0.91
|
32
|
A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations.
|
Histopathology
|
2009
|
0.91
|
33
|
Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia.
|
J Clin Endocrinol Metab
|
2003
|
0.90
|
34
|
BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion?
|
Hum Pathol
|
2009
|
0.89
|
35
|
Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes.
|
Genes Chromosomes Cancer
|
2012
|
0.88
|
36
|
A polymorphism in the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto's thyroiditis susceptibility.
|
J Clin Endocrinol Metab
|
2014
|
0.86
|
37
|
Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations.
|
BMC Cancer
|
2009
|
0.86
|
38
|
Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?
|
Int J Surg Pathol
|
2014
|
0.86
|
39
|
Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes.
|
J Pathol
|
2005
|
0.85
|
40
|
Cancer: Small papillary thyroid cancers--is BRAF of prognostic value?
|
Nat Rev Endocrinol
|
2011
|
0.85
|
41
|
RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.
|
Histopathology
|
2012
|
0.85
|
42
|
Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later.
|
J Clin Endocrinol Metab
|
2013
|
0.84
|
43
|
A stem cell role for thyroid solid cell nests.
|
Hum Pathol
|
2005
|
0.84
|
44
|
Small-cell (basaloid) thyroid carcinoma: a neoplasm with a solid cell nest histogenesis?
|
Int J Surg Pathol
|
2011
|
0.83
|
45
|
Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva: a study from Mozambique.
|
Eur J Cancer Prev
|
2013
|
0.83
|
46
|
The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma.
|
Hum Pathol
|
2006
|
0.83
|
47
|
Follicular, papillary, and "hybrid" carcinomas of the thyroid.
|
Endocr Pathol
|
2002
|
0.83
|
48
|
GRIM-19 in Health and Disease.
|
Adv Anat Pathol
|
2008
|
0.82
|
49
|
Absence of the BRAF and the GRIM-19 mutations in oncocytic (Hürthle cell) solid cell nests of the thyroid.
|
Am J Clin Pathol
|
2012
|
0.81
|
50
|
Mitochondria and cancer.
|
Virchows Arch
|
2009
|
0.81
|
51
|
Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma.
|
Clin Endocrinol (Oxf)
|
2008
|
0.81
|
52
|
The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.
|
Virchows Arch
|
2011
|
0.81
|
53
|
Head and neck lesions in a cohort irradiated in childhood for tinea capitis treatment.
|
Lancet Infect Dis
|
2011
|
0.80
|
54
|
A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.
|
Int J Surg Pathol
|
2005
|
0.80
|
55
|
AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines.
|
PLoS One
|
2012
|
0.80
|
56
|
CDX2 Expression in Some Variants of Papillary Thyroid Carcinoma.
|
Am J Clin Pathol
|
2012
|
0.79
|
57
|
Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach.
|
J Pathol
|
2002
|
0.79
|
58
|
Tumor-in-tumor of the thyroid with basaloid differentiation: a lesion with a solid cell nest neoplastic component?
|
Int J Surg Pathol
|
2011
|
0.79
|
59
|
Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
|
Mitochondrion
|
2005
|
0.78
|
60
|
Small cell tumors of the thyroid gland: a review.
|
Int J Surg Pathol
|
2013
|
0.78
|
61
|
Warthin's tumour.
|
Virchows Arch
|
2006
|
0.78
|
62
|
Diagnostic criteria in well-differentiated thyroid carcinomas.
|
Endocr Pathol
|
2006
|
0.78
|
63
|
Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
|
Int J Surg Pathol
|
2013
|
0.78
|
64
|
Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas.
|
Cancer Lett
|
2005
|
0.77
|
65
|
Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases.
|
Histopathology
|
2013
|
0.77
|
66
|
In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp.
|
Endocr Relat Cancer
|
2011
|
0.77
|
67
|
Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment.
|
Eur J Endocrinol
|
2013
|
0.77
|
68
|
Thyroid and parathyroid tumours in patients submitted to X-ray scalp epilation during the tinea capitis eradication campaign in the North of Portugal (1950-1963).
|
Virchows Arch
|
2014
|
0.77
|
69
|
Increased lymphangiogenesis in Riedel thyroiditis (Immunoglobulin G4-related thyroid disease).
|
Virchows Arch
|
2014
|
0.76
|
70
|
A founder SDHB mutation in Portuguese paraganglioma patients.
|
Endocr Relat Cancer
|
2013
|
0.76
|
71
|
Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth.
|
Hum Pathol
|
2008
|
0.76
|
72
|
Alterations of the SDHD gene locus in midgut carcinoids.
|
Genes Chromosomes Cancer
|
2003
|
0.76
|
73
|
Poorly Differentiated and Undifferentiated Thyroid Carcinomas.
|
Turk Patoloji Derg
|
2015
|
0.76
|
74
|
Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex.
|
Virchows Arch
|
2002
|
0.76
|
75
|
Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
|
BMC Cancer
|
2004
|
0.75
|
76
|
Re: Lohrer,H.D., Hieber,L. and Zitzelsberger,H. (2002) Differential mutation frequency in mitochondrial DNA from thyroid tumours. Carcinogenesis, 23, 1577-1582.
|
Carcinogenesis
|
2003
|
0.75
|
77
|
Difficult cases of thyroid pathology.
|
Endocr Pathol
|
2002
|
0.75
|
78
|
Is BRAF mutation screening useful for preoperative risk stratification in papillary thyroid cancer?
|
Future Oncol
|
2009
|
0.75
|
79
|
Reply to 'The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors'.
|
Mod Pathol
|
2013
|
0.75
|
80
|
Hyalinizing trabecular tumor of the thyroid displaying neuroendocrine differentiation.
|
Virchows Arch
|
2004
|
0.75
|
81
|
Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases.
|
Am J Surg Pathol
|
2017
|
0.75
|
82
|
C-cell hyperplasia and papillary thyroid carcinoma.
|
Int J Surg Pathol
|
2012
|
0.75
|
83
|
Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.
|
Cytogenet Genome Res
|
2017
|
0.75
|
84
|
Endoscopic ultrasonographic features of gastric mucosa-associated lymphoid tissue lymphoma with a 'pseudocircumvolutory' appearance.
|
Can J Gastroenterol
|
2013
|
0.75
|
85
|
Cystic tumor of the atrioventricular node of the heart appears to be the heart equivalent of the solid cell nests (ultimobranchial rests) of the thyroid.
|
Am J Clin Pathol
|
2005
|
0.75
|
86
|
Travelogue.
|
Int J Surg Pathol
|
2010
|
0.75
|
87
|
The familial counterparts of follicular cell--derived thyroid tumors.
|
Int J Surg Pathol
|
2010
|
0.75
|
88
|
MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
|
Eur J Endocrinol
|
2012
|
0.75
|
89
|
Vascular invasion in thyroid and gastric carcinomas.
|
Ultrastruct Pathol
|
2003
|
0.75
|